The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial. | |
MedLine Citation:
|
PMID: 25238659 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVES: To determine the effects of addition of different dosages of gonadotrophin releasing hormone agonist (GnRH-a) to routine luteal phase support (LPS) on implantation and pregnancy rates. STUDY DESIGN: Three hundred infertile couples who were treated by intracytoplasmic sperm injection and embryo transfer (ICSI-ET) following controlled ovarian stimulation (COS) with long luteal GnRH agonist protocol were enrolled. All women received 600mg/day vaginal micronized progesterone plus 4mg 17β estradiol for LPS starting from the day of oocyte retrieval. Patients (n=300) were randomized into three treatment groups. Group A (n=100) received leuprolide acetate 1mg s.c. injection 3 days after ET in addition to routine LPS. Group B (n=100) received two sequential doses of leuprolide acetate 1mg s.c. injections 3 and 6 days after ET in addition to routine LPS. Control group (n=100) received only the routine LPS. RESULTS: A total of 279 patients completed the study. The groups were comparable in terms of baseline demographic parameters including age, duration of infertility and day 3 levels of FSH and estradiol. The cycle parameters of the groups were also comparable regarding the E2 level on day of hCG, number of retrieved oocytes, number of day 3 embryos, number of embryos transferred, and endometrial thickness on both days of OPU and ET. The implantation rates were similar in between the Groups A, B, and control group (20.7% and 25.8% vs. 13.3%, respectively; P=.099). The clinical pregnancy rates and miscarriage rates were similar in between the groups. The ongoing pregnancy rates were 27.4% in control group, 36% in Group A and 42.9% in Group B (P=.093). The OHSS rates were comparable in between the groups. The multiple pregnancy rates were significantly higher in Groups A and B than in control group (12% and 17.9% vs. 4.2%, respectively; P=.014). CONCLUSIONS: The implantation, clinical pregnancy and ongoing pregnancy and multiple pregnancy rates seem to be increased with the addition of GnRH-a to routine luteal phase support. |
Authors:
|
Gülşah Aynaoğlu Yıldız; Yavuz Emre Sükür; Can Ateş; Ruşen Aytaç |
Related Documents
:
|
11887219 - Reproductive experience influences grooming behavior during pregnancy in rats. 18345969 - Managing headache during pregnancy and lactation. 10468059 - Pregnancy-related back and pelvic pain and changes in bone density. 15708489 - Chronic caffeine or theophylline intake during pregnancy inhibits a1 receptor function ... 1570209 - Ketogenesis from lactate in rat liver during the perinatal period. 25238659 - The addition of gonadotrophin releasing hormone agonist to routine luteal phase support... 18997569 - Efficacy of the marquette method of natural family planning. 9788649 - Blunted fetal response to vibroacoustic stimulation following chronic exposure to propr... 24685319 - Pregnancy and pulmonary hypertension. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2014-8-27 |
Journal Detail:
|
Title: European journal of obstetrics, gynecology, and reproductive biology Volume: 182C ISSN: 1872-7654 ISO Abbreviation: Eur. J. Obstet. Gynecol. Reprod. Biol. Publication Date: 2014 Aug |
Date Detail:
|
Created Date: 2014-9-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375672 Medline TA: Eur J Obstet Gynecol Reprod Biol Country: - |
Other Details:
|
Languages: ENG Pagination: 66-70 Citation Subset: - |
Copyright Information:
|
Copyright © 2014. Published by Elsevier Ireland Ltd. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
MeSH Terms | |
Descriptor/Qualifier:
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost...
Next Document: Reward sensitivity, attentional bias, and executive control in early adolescent alcohol use.